Literature DB >> 12407224

Glutamate receptor trafficking in synaptic plasticity.

Anis Contractor1, Stephen F Heinemann.   

Abstract

Ionotropic glutamate receptors mediate excitatory synaptic transmission at most central mammalian synapses. In addition to converting the chemical signal released from the presynaptic terminal to an electrical response in the postsynaptic neuron, these receptors are critically involved in activity-dependent, long-term changes in synaptic strength and, therefore, are central to processes thought to underlie learning and memory. Several mechanisms have been proposed to play roles in altering synaptic strength, and it is clear that there are several different forms of long-term synaptic plasticity in the mammalian brain. Here, we review recent evidence that some forms of synaptic strengthening rely on the modification of the glutamate receptor complement at synapses in response to activity-dependent processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407224     DOI: 10.1126/stke.2002.156.re14

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  14 in total

1.  Impaired synaptic plasticity and learning in mice lacking beta-adducin, an actin-regulating protein.

Authors:  Rebecca L Rabenstein; Nii A Addy; Barbara J Caldarone; Yukiko Asaka; Lore M Gruenbaum; Luanne L Peters; Diana M Gilligan; Reiko M Fitzsimonds; Marina R Picciotto
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

Review 2.  Modulation of the NMDA Receptor Through Secreted Soluble Factors.

Authors:  Waldo Cerpa; Eva Ramos-Fernández; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2014-11-29       Impact factor: 5.590

3.  Acute Hyperglycemia Increases Brain Pregenual Anterior Cingulate Cortex Glutamate Concentrations in Type 1 Diabetes.

Authors:  Nicolas R Bolo; Alan M Jacobson; Gail Musen; Matcheri S Keshavan; Donald C Simonson
Journal:  Diabetes       Date:  2020-04-15       Impact factor: 9.461

Review 4.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

5.  A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens.

Authors:  Lawrence Fourgeaud; Susana Mato; Delphine Bouchet; Agnès Hémar; Paul F Worley; Olivier J Manzoni
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

6.  Platelet kainate receptor signaling promotes thrombosis by stimulating cyclooxygenase activation.

Authors:  Henry Sun; AnneMarie Swaim; Jesus Enrique Herrera; Diane Becker; Lewis Becker; Kalyan Srivastava; Laura E Thompson; Michelle R Shero; Alita Perez-Tamayo; Bhoom Suktitipat; Rasika Mathias; Anis Contractor; Nauder Faraday; Craig N Morrell
Journal:  Circ Res       Date:  2009-08-13       Impact factor: 17.367

Review 7.  Proton Magnetic Resonance Spectroscopy: Relevance of Glutamate and GABA to Neuropsychology.

Authors:  Gabriele Ende
Journal:  Neuropsychol Rev       Date:  2015-08-12       Impact factor: 7.444

Review 8.  Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury.

Authors:  Christopher R Dorsett; Jennifer L McGuire; Erica A K DePasquale; Amanda E Gardner; Candace L Floyd; Robert E McCullumsmith
Journal:  J Neurotrauma       Date:  2016-07-06       Impact factor: 5.269

9.  Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Authors:  Shayla E Russell; Daniel J Puttick; Allison M Sawyer; David N Potter; Stephen Mague; William A Carlezon; Elena H Chartoff
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

10.  AMPA receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia.

Authors:  John C Hammond; James H Meador-Woodruff; Vahram Haroutunian; Robert E McCullumsmith
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.